These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 24065921)
1. A thermosensitive mutation alters the effects of lacosamide on slow inactivation in neuronal voltage-gated sodium channels, NaV1.2. Abdelsayed M; Sokolov S; Ruben PC Front Pharmacol; 2013; 4():121. PubMed ID: 24065921 [TBL] [Abstract][Full Text] [Related]
2. A thermoprotective role of the sodium channel β1 subunit is lost with the β1 (C121W) mutation. Egri C; Vilin YY; Ruben PC Epilepsia; 2012 Mar; 53(3):494-505. PubMed ID: 22292491 [TBL] [Abstract][Full Text] [Related]
3. β1-C121W Is Down But Not Out: Epilepsy-Associated Scn1b-C121W Results in a Deleterious Gain-of-Function. Kruger LC; O'Malley HA; Hull JM; Kleeman A; Patino GA; Isom LL J Neurosci; 2016 Jun; 36(23):6213-24. PubMed ID: 27277800 [TBL] [Abstract][Full Text] [Related]
4. Enhanced in vitro CA1 network activity in a sodium channel β1(C121W) subunit model of genetic epilepsy. Hatch RJ; Reid CA; Petrou S Epilepsia; 2014 Apr; 55(4):601-8. PubMed ID: 24605816 [TBL] [Abstract][Full Text] [Related]
5. Febrile temperatures unmask biophysical defects in Nav1.1 epilepsy mutations supportive of seizure initiation. Volkers L; Kahlig KM; Das JH; van Kempen MJ; Lindhout D; Koeleman BP; Rook MB J Gen Physiol; 2013 Dec; 142(6):641-53. PubMed ID: 24277604 [TBL] [Abstract][Full Text] [Related]
7. Voltage-gated sodium channels: pharmaceutical targets via anticonvulsants to treat epileptic syndromes. Abdelsayed M; Sokolov S Channels (Austin); 2013; 7(3):146-52. PubMed ID: 23531742 [TBL] [Abstract][Full Text] [Related]
8. Functional modulation of voltage-dependent sodium channel expression by wild type and mutated C121W-β1 subunit. Baroni D; Barbieri R; Picco C; Moran O J Bioenerg Biomembr; 2013 Aug; 45(4):353-68. PubMed ID: 23584539 [TBL] [Abstract][Full Text] [Related]
9. A sodium channel mutation causing epilepsy in man exhibits subtle defects in fast inactivation and activation in vitro. Alekov A; Rahman MM; Mitrovic N; Lehmann-Horn F; Lerche H J Physiol; 2000 Dec; 529 Pt 3(Pt 3):533-9. PubMed ID: 11118488 [TBL] [Abstract][Full Text] [Related]
10. Differential gene expression profiles of two excitable rat cell lines after over-expression of WT- and C121W-β1 sodium channel subunits. Baroni D; Moran O Neuroscience; 2015 Jun; 297():105-17. PubMed ID: 25827112 [TBL] [Abstract][Full Text] [Related]
11. Functional and biochemical analysis of a sodium channel beta1 subunit mutation responsible for generalized epilepsy with febrile seizures plus type 1. Meadows LS; Malhotra J; Loukas A; Thyagarajan V; Kazen-Gillespie KA; Koopman MC; Kriegler S; Isom LL; Ragsdale DS J Neurosci; 2002 Dec; 22(24):10699-709. PubMed ID: 12486163 [TBL] [Abstract][Full Text] [Related]
12. Generalized epilepsy with febrile seizures plus type 2 mutation W1204R alters voltage-dependent gating of Na(v)1.1 sodium channels. Spampanato J; Escayg A; Meisler MH; Goldin AL Neuroscience; 2003; 116(1):37-48. PubMed ID: 12535936 [TBL] [Abstract][Full Text] [Related]
13. Enhanced inactivation and acceleration of activation of the sodium channel associated with epilepsy in man. Alekov AK; Rahman MM; Mitrovic N; Lehmann-Horn F; Lerche H Eur J Neurosci; 2001 Jun; 13(11):2171-6. PubMed ID: 11422459 [TBL] [Abstract][Full Text] [Related]
14. A mutation of SCN1B associated with GEFS+ causes functional and maturation defects of the voltage-dependent sodium channel. Baroni D; Picco C; Moran O Hum Mutat; 2018 Oct; 39(10):1402-1415. PubMed ID: 29992740 [TBL] [Abstract][Full Text] [Related]
15. Axon initial segment dysfunction in a mouse model of genetic epilepsy with febrile seizures plus. Wimmer VC; Reid CA; Mitchell S; Richards KL; Scaf BB; Leaw BT; Hill EL; Royeck M; Horstmann MT; Cromer BA; Davies PJ; Xu R; Lerche H; Berkovic SF; Beck H; Petrou S J Clin Invest; 2010 Aug; 120(8):2661-71. PubMed ID: 20628201 [TBL] [Abstract][Full Text] [Related]
16. CRMP2 protein SUMOylation modulates NaV1.7 channel trafficking. Dustrude ET; Wilson SM; Ju W; Xiao Y; Khanna R J Biol Chem; 2013 Aug; 288(34):24316-31. PubMed ID: 23836888 [TBL] [Abstract][Full Text] [Related]
17. A novel epilepsy mutation in the sodium channel SCN1A identifies a cytoplasmic domain for beta subunit interaction. Spampanato J; Kearney JA; de Haan G; McEwen DP; Escayg A; Aradi I; MacDonald BT; Levin SI; Soltesz I; Benna P; Montalenti E; Isom LL; Goldin AL; Meisler MH J Neurosci; 2004 Nov; 24(44):10022-34. PubMed ID: 15525788 [TBL] [Abstract][Full Text] [Related]
18. Differential effect of lacosamide on Nav1.7 variants from responsive and non-responsive patients with small fibre neuropathy. Labau JIR; Estacion M; Tanaka BS; de Greef BTA; Hoeijmakers JGJ; Geerts M; Gerrits MM; Smeets HJM; Faber CG; Merkies ISJ; Lauria G; Dib-Hajj SD; Waxman SG Brain; 2020 Mar; 143(3):771-782. PubMed ID: 32011655 [TBL] [Abstract][Full Text] [Related]
19. Lacosamide Inhibition of Na Labau JIR; Alsaloum M; Estacion M; Tanaka B; Dib-Hajj FB; Lauria G; Smeets HJM; Faber CG; Dib-Hajj S; Waxman SG Front Pharmacol; 2021; 12():791740. PubMed ID: 34992539 [TBL] [Abstract][Full Text] [Related]
20. Mutations in SCN3A cause early infantile epileptic encephalopathy. Zaman T; Helbig I; Božović IB; DeBrosse SD; Bergqvist AC; Wallis K; Medne L; Maver A; Peterlin B; Helbig KL; Zhang X; Goldberg EM Ann Neurol; 2018 Apr; 83(4):703-717. PubMed ID: 29466837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]